Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
TESARO RG (NQ: TSRO)
53.02 USD  +1.04 (+2.00%)
Official Closing Price  /  Updated: 8:00 PM EDT, Apr 24, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 901,933
Open 52.49
Bid (Size) 52.02 (100)
Ask (Size) 54.00 (100)
Prev. Close 51.98
Today's Range 52.08 - 53.82
52wk Range 50.67 - 168.92
Shares Outstanding 54,801,636
Dividend Yield N/A
Performance
YTD
-29.89%
-29.89%
1 Month
-10.18%
-10.18%
3 Month
-27.30%
-27.30%
6 Month
-52.82%
-52.82%
1 Year
-61.34%
-61.34%
Top News
More News
TESARO Announces Positive Top-Line Results From Quadra Trial of ZEJULA®
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced results from the QUADRA study, which was designed to assess clinical benefit of ZEJULA® treatment in heavily... Read More
from GlobeNewswire News Releases
New Research Coverage Highlights MPLX LP, TESARO, LKQ, Cytokinetics, Keysight Technologies, and Charles River Laboratories International — Consolidated Revenues, Company Growth, and Expectations for 2
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MPLX LP (NYSE:MPLX),... Read More
from GlobeNewswire News Releases
More News
Read More
TESARO to Announce First-Quarter 2018 Financial Results on May 3, 2018
from GlobeNewswire News Releases
TESARO Summarizes TSR-042 Clinical Data Presented at AACR
from GlobeNewswire News Releases
Can This Smaller Biotech Actually Rival Merck, Bristol In Cancer Drugs?
from Investor's Business Daily
TESARO and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA® in Israel
from GlobeNewswire News Releases
Clovis Pops After Ovarian Cancer Drug Gets FDA Win; Tesaro Topples
from Investor's Business Daily
Tesaro Inc Has Returned 14.0% Since SmarTrend Recommendation (TSRO)
from Comtex SmarTrend® News Briefs
Noteworthy Monday Option Activity: TSRO, ERI, WSM
category Stocks
from Market News Video
Tesaro Inc Shares Down 9.5% Since SmarTrend's Sell Call (TSRO)
from Comtex SmarTrend® News Briefs
BRIEF-Tesaro Summarizes TSR-042 Clinical Data Presented At AACR
category companyNews
from Reuters: Company News
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial